With the factor XI inhibitor, clinicians may have more flexibility when managing anticoagulation in this common scenario.

Cadrenal Therapeutics, Inc. , a biopharmaceutical company developing novel therapeutics for patients with cardiovascular disease, today announced new findings from third-party research on the economic ...

There is an apparent underuse of warfarin in elderly patients with AF, as there is inconsistency in opinion among clinicians about who should receive anticoagulation. The risks of warfarin are ...

As we observed World Heart Rhythm Week (June 2–8, 2025), the theme “One Heart, Many Rhythms” underscored the importance of ...

– For people who have heart failure with a normal heart rhythm, there seems to be little to no advantage of warfarin (an anticoagulant: a medicine which prevents blood clotting by blocking proteins) ...

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its incidence increases with age. Current data suggest that anticoagulation with warfarin or dabigatran is far superior to ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...

The Ischemic Stroke Epidemiology Forecast Report 2025-2034 offers extensive analysis on prevalence trends and demographic influences of ischemic stroke globally. Covering eight key markets, it details ...

(NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of BRUKINSA ® (zanubrutinib) ...

Sounds dramatic, but when it comes to certain dietary supplements, even a slight overdose can send your ticker into chaos. We ...

I've been diagnosed with atrial fibrillation. I've read that it puts me at greater risk of stroke. Can you tell me more about ...

Atrial fibrillation is a common type of heart rhythm disorder where the heart doesn't beat efficiently. This makes the heart ...